-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
G1 Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
- G1 Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.54M, a 131% decline year-over-year.
- G1 Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$37.9M, a 43.2% increase year-over-year.
- G1 Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$39.5M, a 71% increase from 2022.
- G1 Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$136M, a 4.41% increase from 2021.
- G1 Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$142M, a 47.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)